Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for…
Boehringer Ingelheim holds a valid patent for Linagliptin in India until August 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
anti-diabetes drug
DawaaDost announces one day’s Diabetes course of ‘Metformin 1000 mg’ at Re 1 per day
Through this programme, DawaaDost will retail Metformin 1000 mg tablets from the top 10 pharmaceutical companies in the country
Micro Labs launches anti-diabetic drug combo, Dapagliflozin plus Metformin
The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80